1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and the ...
1 Non-GAAP cost of product revenues excludes the amortization of licensed intellectual property for Iclusig relating to the acquisition of the European business of ARIAD Pharmaceuticals, Inc. and the ...
(*) Consists of charges to cost of revenues for the difference between the fair value of acquired inventory in business combination, which was recorded at fair value, and the actual cost of this ...
Kitchenware and home goods retailer Williams-Sonoma (NYSE:WSM) reported Q3 CY2025 results beating Wall Street’s revenue ...
Following first-quarter results, Moderna maintained its 2025 outlook and lowered operating cost guidance for 2026-27, with GAAP costs expected to fall by $1.4 billion-$1.7 billion between 2025 and ...
GAAP revenue grew nearly sevenfold from Q2 2024 to Q2 2025, driven by the first Energy Base battery project sales. GAAP net loss and cash burn improved significantly year over year, with GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback